Dr. Euguenia Kharmlampieva, CNMB Co-director, is among 3 UAB chemists fighting cancer. Kharlampieva and Veronika Kozlovskaya, Ph.D., research associate in Kharlampieva’s lab and her longtime collaborator, have created a cloaking device for fragile anti-cancer drugs. Their nanocapsules can be 60 times smaller than a red blood cell and produced at industrial scale. And they are smart; that is, they can release their cargo at precise locations when triggered by a burst of ultrasound energy, a specified temperature or the acidic environment around cancer cells. Click here to see original article in it’s entirety as published in the UAB Reporter.
Dr. Eugenia Kharlampieva
Congratulations to Dr. Eugenia Khamlampieva on her new National Science Foundation grant for MRI: Acquisition of an Atomic Force Microscope for Materials Research and Education. You can read about it here.
Congratulations to Dr. Eugenia Kharlampieva
Dr. Eugenia Kharlampieva has been appointed as Co-Director of the Center for Nanoscale Materials and Biointergration. Dr. Kharlampieva’s primary appointment is Associate Professor in the College of Arts and Sciences Department of Chemistry where her research is in the design of polymeric materials for biomedical applications. Her lab works on synthesis and assembly of water-soluble stimuli-responsive macromolecules to develop novel nanostructured materials as “intelligent” platforms for therapeutic applications such as controlled drug delivery, regenerative medicine, and biosensing.
Dr. Kharlampieva joined the Chemistry faculty in 2010 from Georgia Institute of Technology. Since coming to UAB, she has authored more than 50 peer-reviewed publication and five book chapters. Dr. Kharlampieva was a recipient of NSF CAREER Award, UAB Dean’s Award for Excellence in Mentorship, UAB College of Arts and Sciences Interdisciplinary Innovation Award, Faculty Innovator of the Year Award from the UAB Bill L. Harbert Institute for Innovation and Entrepreneurship. She was named as an Emerging Investigator by the Royal Society of Chemistry, Journal of Materials Chemistry B.
In her role as Co-Director of the CNMB, her primary responsibilities will be assisting in advancing the mission of the Center which is to promote interdisciplinary research and student training in the synthesis and characterization of nanoscale materials with broad applicability in materials under extreme environments, nano-enabled biomedical imaging and drug delivery platforms, and nanostructured coatings and materials for biomedical implants and vascular grafts. Dr. Kharlampieva will play an instrumental role in aiding in the achievement of core-objectives of CNMB, identify and lead interdisciplinary grant opportunities, contribute to acquiring new and maintaining existing core facilities.
Read UAB News article titled “Stealth pig cells may hold key to treating diabetes in humans,” featuring CNMB member, Dr. Eugenia Kharlempieva.